Ganiraju Manyam

17PUBLICATIONS
156CO-AUTHORS
Innate immunityPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 28, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

Shady I Tantawy, Burcu Aslan, Ganiraju Manyam

|Apr 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

Varsha Gandhi, Shady Tantawy, Burcu Aslan

|Jan 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial.

Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose

|Aug 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.

Chuandong Geng, Man-Chao Zhang, Ganiraju C Manyam

Pageof 3